碳酸甲酸蜂巢基架药物输送系统用于修复骨质疏松性骨缺陷
Koichiro Hayashi1, Cheng Zhang1, Ahmad Nazir Taleb Alashkar1
1Department of Biomaterials, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
ACS applied materials & interfaces
|August 25, 2024
概括
这项研究结合了骨组织工程和药物输送来修复骨质疏松性骨缺陷. 这种新的方法使用带有抗硬质素抗体的蜂颗粒有效地恢复了子的骨质量和质量.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 整形外科 整形外科 整形外科
背景情况:
- 骨质疏松性骨缺陷在老年患者中构成重大挑战.
- 目前的治疗方法往往无法完全恢复骨的数量和质量.
研究的目的:
- 开发和评估一个结合骨组织工程 (BTE) 和药物输送系统 (DDS) 来修复骨质疏松性骨缺陷.
- 在子模型中研究抗硬质素抗体载入蜂颗粒 (Scl-Ab-HCGs) 的疗效.
主要方法:
- 制造蜂颗粒 (HCG) 的碳酸酸微球与多尺度的毛孔.
- 用抗硬质素抗体 (Scl-Abs) 装载HCG,以创建Scl-Ab-HCG,用于对pH反应的药物输送.
- 在卵巢切除的子骨质疏松性股骨中,对HCG单疗法和基于Scl-Ab-HCG的DDS的评估.
主要成果:
- HCG单疗改善了骨质形成,但没有防止RANKL过度表达或完全恢复骨质量.
- 基于Scl-Ab-HCG的DDS促进了表达骨素的新骨形成,类似于正常骨.
- 基于Scl-Ab-HCG的DDS组显示了与正常骨相比的骨细胞亡,骨量和骨质细胞数量.
结论:
- 基于Scl-Ab-HCG的DDS是有效修复骨质疏松性骨缺陷的有希望的策略.
- 这种方法通过调节骨质稳态并防止RANKL过度表达来解决HCG单疗的局限性.
相关概念视频
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K


